Print

Momenta Pharmaceuticals, Inc. (MNTA) to Present at the Leerink Swann and Company 2012 Global Healthcare Conference  
2/14/2012 9:55:25 AM

CAMBRIDGE, Mass., Feb. 13, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA - News), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced its participation at the upcoming Leerink Swann 2012 Global Healthcare Conference taking place in New York, NY. Richard P. Shea, Chief Financial Officer, will participate in a question and answer session on Wednesday, February 15, 2012 at 8:30 a.m. ET. A live audio webcast of the presentation will be available on the "Investors" section of the Company's website located at www.momentapharma.com. A replay of the presentation will be posted on the Momenta website approximately one hour after the event and will be available through May 15, 2012.
//-->